Docetaxel
CAS 114977-28-5 28 FDA-DMF suppliersSmall Molecule
Overview
Docetaxel is a chemotherapy medication that works by interfering with cell division, used primarily in the treatment of breast, lung, prostate, and other cancers. It is a semi-synthetic analogue of paclitaxel and functions as a microtubule inhibitor.
API suppliers (23)
Suppliers of Docetaxel backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- SCINOPHARM TAIWAN LTD3 active DMF
- INDENA SPAItaly2 active DMF
- MSN Laboratories Private LimitedIndia2 active DMF
- Qilu Pharmaceutical Co., Ltd.China1 active DMF
- JIANGSU HENGRUI PHARMACEUTICALS CO LTDChina1 active DMF
- Yifan Pharmaceutical Co., Ltd.China1 active DMF
- BIOVECTRA INCCanada1 active DMF
- BIOVECTRA INCCanada1 active DMF
- TAPI NL BV1 active DMF
- Laurus Labs LimitedIndia1 active DMF
- Cycle Pharmaceuticals Ltd.United Kingdom1 active DMF
- JIANGSU HENGRUI PHARMACEUTICALS CO LTDChina1 active DMF
- FUJIAN KERUI PHARMACEUTICAL CO LTDChina1 active DMF
- Intas Pharmaceuticals Ltd.India1 active DMF
- MAC CHEM PRODUCTS INDIA PVT LTD
- SAI PHYTOCEUTICALS PVT LTD
- PTC Therapeutics, Inc.United States
- Accord Healthcare LtdUnited Kingdom
- FRESENIUS KABI ONCOLOGY LTD
- ARCH PHARMALABS LTD
- Zhejiang Hisun Pharmaceutical Co., Ltd.China
- SAMYANG HOLDINGS CORP
- Sichuan Baili Pharmaceutical Co., Ltd.China
Therapeutic areas
CancerBreast CancerProstate Cancer
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.